Elsie Biotechnologies - Ownership and Business Overview

Life ScienceCompany

Elsie Biotechnologies Ownership

Who owns Elsie Biotechnologies?

Elsie Biotechnologies is owned by GlaxoSmithKline. It was acquired on June 6, 2024.

Elsie Biotechnologies Business Overview

Where is Elsie Biotechnologies headquartered?

Elsie Biotechnologies is headquartered in San Diego, California.

What sector is Elsie Biotechnologies in?

Elsie Biotechnologies is a life science company.

Life Science M&A Summary in 2024

Out of 60 sectors in the Mergr database, life science ranked 7 in number of deals in 2024. The largest life science acquisition in 2024 was Catalent - which was acquired by Novo Holdings A/S for $16.5B.

Join Mergr to view all 161 acquisitions of life science companies in 2024, including 14 acquisitions by private equity firms, and 147 by strategics.

Elsie Biotechnologies

Elsie Biotechnologies

10355 Science Center Dr,
San Diego, California 92121
United States,
www.elsiebio.com

Elsie is a private biopharmaceutical company dedicated to unlocking the full potential of oligonucleotide therapeutics by integrating discovery, development, and delivery to potentially increase potency, decrease toxicity, and optimise delivery. Elsie Biotechnologies is based in San Diego, California


 Subscribe to unlock this and 206,577
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 199K M&A Transactions
  • 202K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 80K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.